Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy-Science-Chemical Encyclopedia-lookchem

Predictors of response to treatment with Actovegin (cas 63748-11-8) for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy
Add time:07/12/2019 Source:sciencedirect.com

AimsTo evaluate two definitions of response and the predictive value of baseline covariates for response to Actovegin (cas 63748-11-8) treatment in type 2 diabetic patients with symptomatic diabetic sensorimotor polyneuropathy (DSPN).

We also recommend Trading Suppliers and Manufacturers of Actovegin (cas 63748-11-8). Pls Click Website Link as below: cas 63748-11-8 suppliers

Prev:Asymmetric synthesis of di- and trisubstituted pyrrolidinones via zirconium-mediated intramolecular coupling of N-3-alkenyl carbamates
Next: Pleiotropic neuroprotective and metabolic effects of Actovegin (cas 63748-11-8)'s mode of action)

Click to view details

Health and Chemicalmore >